ArticleOncoimmunology
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
Sylvie Rusakiewicz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
cites it